Search research articles
Contact Us
Filters
Showing results (601-610 of 611) with videos related to
Page
of 62
Sort By:
Journal of the International AIDS Society
|
January 21, 2021
Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis
Lorna Dunning, Aditya R Gandhi, Martina Penazzato, et al.
The Lancet. Global Health
|
July 25, 2025
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care
Emily P Hyle, Thulani Maphosa, Ajay Rangaraj, et al.
JAMA Network Open
|
December 22, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
European Urology Oncology
|
May 26, 2023
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
Ilon C Weinstein, Xian Wu, Alexander Hill, et al.
AIDS (London, England)
|
April 26, 2022
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India
Pooyan Kazemian, Delaney D Ding, Justine A Scott, et al.
AIDS and Behavior
|
February 6, 2021
Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections
Anne M Neilan, Audrey C Bangs, Michael Hudgens, et al.
The New England Journal of Medicine
|
November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples
Rochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
The Lancet. HIV
|
August 9, 2025
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study
Emily P Hyle, Linda-Gail Bekker, Suzanne M McCluskey, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study
Christopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Page
of 62
Search research articles
Search
Showing results (601-610 of 611) with videos related to
Sort By:
Page
of 62
Journal of the International AIDS Society
|
January 21, 2021
Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis
Lorna Dunning, Aditya R Gandhi, Martina Penazzato, et al.
The Lancet. Global Health
|
July 25, 2025
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care
Emily P Hyle, Thulani Maphosa, Ajay Rangaraj, et al.
JAMA Network Open
|
December 22, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
European Urology Oncology
|
May 26, 2023
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
Ilon C Weinstein, Xian Wu, Alexander Hill, et al.
AIDS (London, England)
|
April 26, 2022
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India
Pooyan Kazemian, Delaney D Ding, Justine A Scott, et al.
AIDS and Behavior
|
February 6, 2021
Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections
Anne M Neilan, Audrey C Bangs, Michael Hudgens, et al.
The New England Journal of Medicine
|
November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples
Rochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
The Lancet. HIV
|
August 9, 2025
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study
Emily P Hyle, Linda-Gail Bekker, Suzanne M McCluskey, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study
Christopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Page
of 62